The Cost and Financial Burden of Thyroid Cancer on Patients in the US | Endocrinology | JN Learning | AMA Ed Hub [Skip to Content]
[Skip to Content Landing]

The Cost and Financial Burden of Thyroid Cancer on Patients in the USA Review and Directions for Future Research

To identify the key insights or developments described in this article
1 Credit CME
Abstract

Importance  In the US, thyroid cancer has been identified as a cancer type with a high degree of associated financial burden on patients, and survivors of thyroid cancer report higher rates of bankruptcy than those of other cancer types. However, the available literature on the financial burden of thyroid cancer has not yet been described.

Observations  Estimates of the out-of-pocket costs of initial thyroid cancer diagnosis and treatment range widely ($1425-$17 000) and are influenced by age, surgical treatment type, and health insurance coverage. The rates of patient-reported financial burden are heterogeneous (16%-50%) and are rarely compared with those of other cancer types. Independent risk factors of financial burden have included younger age, lack of health insurance, and annual household income of less than $49 000. Two studies measured medical debt associated with thyroid cancer diagnosis and treatment at notably different rates (2.1% vs 18.7%). The bankruptcy incidence at 1 year after cancer diagnosis is highest for thyroid cancer (9.3 per 1000 person-years) than other studied cancer types (ie, lung, uterine, leukemia/lymphoma, colorectal, melanoma, breast, prostate) and 4.39-fold higher than control individuals among those aged 35 to 49 years.

Conclusions and Relevance  Current estimates of the financial burden of thyroid cancer are methodologically limited and are based on cross-sectional analyses of patient-reported data. We propose novel frameworks for new research by improvements in (1) data sourcing and utilization, (2) study design, and (3) pilot interventions. To understand how out-of-pocket thyroid cancer-related expenditures transition to various forms of debt, how households finance ongoing costs of care, and rates at which debts are sent to collection agencies, future research should focus on integrating underutilized sources of primary data, including credit reports, public records, and mortgage-backed securities loan-level data. Improvements in study design, such as the development of prospective cohorts, can allow for more objectively measured estimates of out-of-pocket costs, and robust covariate analysis can further reveal the influence of demographic factors, including age, sex, race, income, and health insurance coverage. Finally, new pilot interventions on cost controls can both enable further study and alleviate financial burden.

Sign in to take quiz and track your certificates

Buy This Activity

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 CME Credit™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.

Article Information

Accepted for Publication: March 19, 2022.

Published Online: May 5, 2022. doi:10.1001/jamaoto.2022.0660

Corresponding Author: Benjamin James, MD, MS, Section of Endocrine Surgery, Division of Surgical Oncology, Department of Surgery, Beth Israel Deaconess Medical Center, 185 Pilgrim Rd, Palmer 605, Boston, MA 02115 (bjames1@bidmc.harvard.edu).

Author Contributions: Dr Uppal had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Concept and design: Uppal, James.

Acquisition, analysis, or interpretation of data: Uppal, James.

Drafting of the manuscript: Uppal, James.

Critical revision of the manuscript for important intellectual content: Uppal, James.

Statistical analysis: Uppal.

Administrative, technical, or material support: James.

Supervision: James.

Conflict of Interest Disclosures: Dr Uppal reports income from Quantifed Ventures and Ironwood Medical Information Technologies outside of the submitted work. No other conflicts were reported.

Funding/Support: This work was supported by the National Institutes of Health (NIH)/NCI R37 CA231957 (Dr Cunningham).

Role of the Funder/Sponsor: The National Institutes of Health had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

References
1.
Committee on Improving the Quality of Cancer Care. In: Levit  L , Balogh  E , Nass  S , Ganz  PA , eds.  Addressing the Challenges of an Aging Population, Board on Health Care Services, Institute of Medicine. Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis. National Academies Press; 2014.
2.
Smith  TJ , Hillner  BE .  Bending the cost curve in cancer care.   N Engl J Med. 2011;364(21):2060-2065. doi:10.1056/NEJMsb1013826PubMedGoogle ScholarCrossref
3.
Mariotto  AB , Yabroff  KR , Shao  Y , Feuer  EJ , Brown  ML .  Projections of the cost of cancer care in the United States: 2010-2020.   J Natl Cancer Inst. 2011;103(2):117-128. doi:10.1093/jnci/djq495PubMedGoogle ScholarCrossref
4.
Schnipper  LE , Davidson  NE , Wollins  DS ,  et al; American Society of Clinical Oncology.  American Society of Clinical Oncology statement: a conceptual framework to assess the value of cancer treatment options.   J Clin Oncol. 2015;33(23):2563-2577. doi:10.1200/JCO.2015.61.6706PubMedGoogle ScholarCrossref
5.
Soni  A . The five most costly conditions, 1996 and 2006: Estimates for the US civilian noninstitutionalized population. Statistical Brief# 248. July 2009. Rockville, MD: Agency for Healthcare Research and Quality. Published online 2009. Accessed January 17, 2022. www.bmedreport.com/archives/7231
6.
Narang  AK , Nicholas  LH .  Out-of-pocket spending and financial burden among Medicare beneficiaries with cancer.   JAMA Oncol. 2017;3(6):757-765. doi:10.1001/jamaoncol.2016.4865PubMedGoogle ScholarCrossref
7.
Bernard  DSM , Farr  SL , Fang  Z .  National estimates of out-of-pocket health care expenditure burdens among nonelderly adults with cancer: 2001 to 2008.   J Clin Oncol. 2011;29(20):2821-2826. doi:10.1200/JCO.2010.33.0522PubMedGoogle ScholarCrossref
8.
Nipp  RD , Kirchhoff  AC , Fair  D ,  et al.  Financial burden in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.   J Clin Oncol. 2017;35(30):3474-3481. doi:10.1200/JCO.2016.71.7066PubMedGoogle ScholarCrossref
9.
Banegas  MP , Guy  GP  Jr , de Moor  JS ,  et al.  For working-age cancer survivors, medical debt and bankruptcy create financial hardships.   Health Aff (Millwood). 2016;35(1):54-61. doi:10.1377/hlthaff.2015.0830PubMedGoogle ScholarCrossref
10.
Zullig  LL , Peppercorn  JM , Schrag  D ,  et al.  Financial distress, use of cost-coping strategies, and adherence to prescription medication among patients with cancer.   J Oncol Pract. 2013;9(6S):60s-63s. doi:10.1200/JOP.2013.000971PubMedGoogle ScholarCrossref
11.
Guy  GP  Jr , Ekwueme  DU , Yabroff  KR ,  et al.  Economic burden of cancer survivorship among adults in the United States.   J Clin Oncol. 2013;31(30):3749-3757. doi:10.1200/JCO.2013.49.1241PubMedGoogle ScholarCrossref
12.
Kale  HP , Carroll  NV .  Self-reported financial burden of cancer care and its effect on physical and mental health-related quality of life among US cancer survivors.   Cancer. 2016;122(8):283-289. doi:10.1002/cncr.29808PubMedGoogle ScholarCrossref
13.
Fenn  KM , Evans  SB , McCorkle  R ,  et al.  Impact of financial burden of cancer on survivors’ quality of life.   J Oncol Pract. 2014;10(5):332-338. doi:10.1200/JOP.2013.001322PubMedGoogle ScholarCrossref
14.
Applewhite  MK , James  BC , Kaplan  SP ,  et al.  Quality of life in thyroid cancer is similar to that of other cancers with worse survival.   World J Surg. 2016;40(3):551-561. doi:10.1007/s00268-015-3300-5PubMedGoogle ScholarCrossref
15.
Ramsey  SD , Bansal  A , Fedorenko  CR ,  et al.  Financial insolvency as a risk factor for early mortality among patients with cancer.   J Clin Oncol. 2016;34(9):980-986. doi:10.1200/JCO.2015.64.6620PubMedGoogle ScholarCrossref
16.
Jagsi  R , Pottow  JAE , Griffith  KA ,  et al.  Long-term financial burden of breast cancer: experiences of a diverse cohort of survivors identified through population-based registries.   J Clin Oncol. 2014;32(12):1269-1276. doi:10.1200/JCO.2013.53.0956PubMedGoogle ScholarCrossref
17.
Yabroff  KR , Dowling  EC , Guy  GP  Jr ,  et al.  Financial hardship associated with cancer in the United States: findings from a population-based sample of adult cancer survivors.   J Clin Oncol. 2016;34(3):259-267. doi:10.1200/JCO.2015.62.0468PubMedGoogle ScholarCrossref
18.
Kent  EE , Forsythe  LP , Yabroff  KR ,  et al.  Are survivors who report cancer-related financial problems more likely to forgo or delay medical care?   Cancer. 2013;119(20):3710-3717. doi:10.1002/cncr.28262PubMedGoogle ScholarCrossref
19.
Han  X , Zhao  J , Zheng  Z , de Moor  JS , Virgo  KS , Yabroff  KR .  Medical financial hardship intensity and financial sacrifice associated with cancer in the United States.   Cancer Epidemiol Biomarkers Prev. 2020;29(2):308-317. doi:10.1158/1055-9965.EPI-19-0460PubMedGoogle ScholarCrossref
20.
Smith  GL , Lopez-Olivo  MA , Advani  PG ,  et al.  Financial burdens of cancer treatment: a systematic review of risk factors and outcomes.   J Natl Compr Canc Netw. 2019;17(10):1184-1192. doi:10.6004/jnccn.2019.7305PubMedGoogle ScholarCrossref
21.
Davies  L , Welch  HG .  Current thyroid cancer trends in the United States.   JAMA Otolaryngol Head Neck Surg. 2014;140(4):317-322. doi:10.1001/jamaoto.2014.1PubMedGoogle ScholarCrossref
22.
Davies  L , Welch  HG .  Thyroid cancer survival in the United States: observational data from 1973 to 2005.   Arch Otolaryngol Head Neck Surg. 2010;136(5):440-444. doi:10.1001/archoto.2010.55PubMedGoogle ScholarCrossref
23.
Blomberg  M , Feldt-Rasmussen  U , Andersen  KK , Kjaer  SK .  Thyroid cancer in Denmark 1943-2008, before and after iodine supplementation.   Int J Cancer. 2012;131(10):2360-2366. doi:10.1002/ijc.27497PubMedGoogle ScholarCrossref
24.
Wang  LY , Palmer  FL , Thomas  D ,  et al.  Preoperative neck ultrasound in clinical node-negative differentiated thyroid cancer.   J Clin Endocrinol Metab. 2014;99(10):3686-3693. doi:10.1210/jc.2014-1681PubMedGoogle ScholarCrossref
25.
Cabanillas  ME , McFadden  DG , Durante  C .  Thyroid cancer.   Lancet. 2016;388(10061):2783-2795. doi:10.1016/S0140-6736(16)30172-6PubMedGoogle ScholarCrossref
26.
Cooper  DS , Doherty  GM , Haugen  BR ,  et al; American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.   Thyroid. 2009;19(11):1167-1214. doi:10.1089/thy.2009.0110PubMedGoogle ScholarCrossref
27.
Aschebrook-Kilfoy  B , Schechter  RB , Shih  YCT ,  et al.  The clinical and economic burden of a sustained increase in thyroid cancer incidence.   Cancer Epidemiol Biomarkers Prev. 2013;22(7):1252-1259. doi:10.1158/1055-9965.EPI-13-0242PubMedGoogle ScholarCrossref
28.
Wang  LY , Roman  BR , Migliacci  JC ,  et al.  Cost-effectiveness analysis of papillary thyroid cancer surveillance.   Cancer. 2015;121(23):4132-4140. doi:10.1002/cncr.29633PubMedGoogle ScholarCrossref
29.
Wu  JX , Beni  CE , Zanocco  KA , Sturgeon  C , Yeh  MW .  Cost-effectiveness of long-term every three-year versus annual postoperative surveillance for low-risk papillary thyroid cancer.   Thyroid. 2015;25(7):797-803. doi:10.1089/thy.2014.0617PubMedGoogle ScholarCrossref
30.
Lubitz  CC , Kong  CY , McMahon  PM ,  et al.  Annual financial impact of well-differentiated thyroid cancer care in the United States.   Cancer. 2014;120(9):1345-1352. doi:10.1002/cncr.28562PubMedGoogle ScholarCrossref
31.
Bhattacharjee  S , Khobrani  M , Alrabiah  Z , Bilal  J , Riaz  IB .  Healthcare expenditures among community-dwelling adults with thyroid cancer in the United States: A propensity score matched analysis.   Heliyon. 2019;5(6):e01995. doi:10.1016/j.heliyon.2019.e01995PubMedGoogle ScholarCrossref
32.
Zheng  F , Huang  Y , Wright  J , Kuo  JH .  Out of pocket costs for patients undergoing thyroid surgery.   Ann Surg. 2021. Published online July 14, 2021. doi:10.1097/SLA.0000000000005078PubMedGoogle ScholarCrossref
33.
Barrows  CE , Belle  JM , Fleishman  A , Lubitz  CC , James  BC .  Financial burden of thyroid cancer in the United States: An estimate of economic and psychological hardship among thyroid cancer survivors.   Surgery. 2020;167(2):378-384. doi:10.1016/j.surg.2019.09.010PubMedGoogle ScholarCrossref
34.
Broekhuis  JM , Li  C , Chen  HW ,  et al.  Patient-reported financial burden in thyroid cancer.   J Surg Res. 2021;266:160-167. doi:10.1016/j.jss.2021.03.051PubMedGoogle ScholarCrossref
35.
Chen  DW , Reyes-Gastelum  D , Veenstra  CM , Hamilton  AS , Banerjee  M , Haymart  MR .  Financial hardship among hispanic women with thyroid cancer.   Thyroid. 2021;31(5):752-759. doi:10.1089/thy.2020.0497PubMedGoogle ScholarCrossref
36.
Gupta  A , Morrison  ER , Fedorenko  C , Ramsey  S . Cancer diagnoses and household debt overhang. Columbia Law and Economics Working Paper. 2015;514. Accessed January 17, 2022. www.mccombs.utexas.edu/~/media/Files/MSB/Centers/HMTF/TFF/CancerLeveragePaper.pdf
37.
Mongelli  MN , Giri  S , Peipert  BJ , Helenowski  IB , Yount  SE , Sturgeon  C .  Financial burden and quality of life among thyroid cancer survivors.   Surgery. 2020;167(3):631-637. doi:10.1016/j.surg.2019.11.014PubMedGoogle ScholarCrossref
38.
Ramsey  S , Blough  D , Kirchhoff  A ,  et al.  Washington State cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis.   Health Aff (Millwood). 2013;32(6):1143-1152. doi:10.1377/hlthaff.2012.1263PubMedGoogle ScholarCrossref
39.
Boltz  MM , Hollenbeak  CS , Schaefer  E , Goldenberg  D , Saunders  BD .  Attributable costs of differentiated thyroid cancer in the elderly Medicare population.   Surgery. 2013;154(6):1363-1369. doi:10.1016/j.surg.2013.06.042PubMedGoogle ScholarCrossref
40.
History of health reform efforts in the United States. KFF. Published March 25, 2011. Accessed March 9, 2022. https://www.kff.org/health-reform/timeline/history-of-health-reform-efforts-in-the-united-states/
41.
Mazzaferri  EL , Jhiang  SM .  Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.   Am J Med. 1994;97(5):418-428. doi:10.1016/0002-9343(94)90321-2PubMedGoogle ScholarCrossref
42.
Ezzati-Rice  TM .  Sample Design of the Medical Expenditure Panel Survey Household Component, 1998-2007. U.S. Department of Health & Human Services, Agency for Healthcare Research and Quality; 2008.
43.
Zafar  SY , Peppercorn  JM , Schrag  D ,  et al.  The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient’s experience.   Oncologist. 2013;18(4):381-390. doi:10.1634/theoncologist.2012-0279PubMedGoogle ScholarCrossref
44.
Nipp  RD , Shui  AM , Perez  GK ,  et al.  Patterns in health care access and affordability among cancer survivors during implementation of the Affordable Care Act.   JAMA Oncol. 2018;4(6):791-797. doi:10.1001/jamaoncol.2018.0097PubMedGoogle ScholarCrossref
45.
Khera  N .  Reporting and grading financial toxicity.   J Clin Oncol. 2014;32(29):3337-3338. doi:10.1200/JCO.2014.57.8740PubMedGoogle ScholarCrossref
46.
Chung  Y . Chronic Health Conditions and Economic Outcomes. Unpublished mimeo. Published online 2013. Accessed January 17, 2022. www.sole-jole.org/assets/docs/14225.pdf
47.
Search the Physician Fee Schedule. Accessed January 17, 2022. www.cms.gov/medicare/physician-fee-schedule/search?Y=0&T=0&HT=0&CT=3&H1=78814&M=5
49.
FY 2022 IPPS final rule home page. Accessed January 17, 2022. www.cms.gov/medicare/acute-inpatient-pps/fy-2022-ipps-final-rule-home-page
50.
MCD search. Accessed January 17, 2022. www.cms.gov/medicare-coverage-database/search.aspx
53.
Henrikson  NB , Chang  E , Ulrich  K , King  D , Anderson  ML .  Communication with physicians about health care costs: Survey of an insured population.   Perm J. 2017;21:16-070. doi:10.7812/TPP/16-070PubMedGoogle ScholarCrossref
54.
Gilligan  T , Coyle  N , Frankel  RM ,  et al.  Patient-clinician communication: American Society of Clinical Oncology Consensus Guideline.   J Clin Oncol. 2017;35(31):3618-3632. doi:10.1200/JCO.2017.75.2311PubMedGoogle ScholarCrossref
55.
Zafar  SY , Chino  F , Ubel  PA ,  et al.  The utility of cost discussions between patients with cancer and oncologists.   Am J Manag Care. 2015;21(9):607-615.PubMedGoogle Scholar
56.
O’Connor  JM , Kircher  SM , de Souza  JA .  Financial toxicity in cancer care.   J Community Support Oncol. 2016;14(3):101-106. doi:10.12788/jcso.0239PubMedGoogle ScholarCrossref
57.
Carrera  PM , Kantarjian  HM , Blinder  VS .  The financial burden and distress of patients with cancer: Understanding and stepping-up action on the financial toxicity of cancer treatment.   CA Cancer J Clin. 2018;68(2):153-165. doi:10.3322/caac.21443PubMedGoogle ScholarCrossref
58.
de Souza  JA , Yap  BJ , Hlubocky  FJ ,  et al.  The development of a financial toxicity patient-reported outcome in cancer: The COST measure.   Cancer. 2014;120(20):3245-3253. doi:10.1002/cncr.28814PubMedGoogle ScholarCrossref
59.
de Souza  JA , Yap  BJ , Wroblewski  K ,  et al.  Measuring financial toxicity as a clinically relevant patient-reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST).   Cancer. 2017;123(3):476-484. doi:10.1002/cncr.30369PubMedGoogle ScholarCrossref
60.
Meisenberg  BR , Varner  A , Ellis  E ,  et al.  Patient attitudes regarding the cost of illness in cancer care.   Oncologist. 2015;20(10):1199-1204. doi:10.1634/theoncologist.2015-0168PubMedGoogle ScholarCrossref
61.
Head  BA , Faul  AC .  Development and validation of a scale to measure socioeconomic well-being in persons with cancer.   J Support Oncol. 2008;6(4):183-192.PubMedGoogle Scholar
62.
Witte  J , Mehlis  K , Surmann  B ,  et al.  Methods for measuring financial toxicity after cancer diagnosis and treatment: a systematic review and its implications.   Ann Oncol. 2019;30(7):1061-1070. doi:10.1093/annonc/mdz140PubMedGoogle ScholarCrossref
63.
Avery  RB , Board of Governors of the Federal Reserve System, Calem  PS , Canner  GB , Bostic  RW .  An overview of consumer data and credit reporting.   Fed Reserv Bull. 2003;89(2).Google Scholar
64.
Dobkin  C , Finkelstein  A , Kluender  R , Notowidigdo  MJ .  The Economic consequences of hospital admissions.   Am Econ Rev. 2018;108(2):308-352. doi:10.1257/aer.20161038PubMedGoogle ScholarCrossref
65.
Bepko  AB .  Public availability or practical obscurity: the debate over public access to court records on the internet.   NY Law Sch Law Rev. 2004;49:967.Google Scholar
66.
Martin  PW .  Online access to court records-from documents to data, particulars to patterns.   Villanova Law Rev. 2008;53:855. doi:10.2139/ssrn.1107412Google ScholarCrossref
If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_Multimedia_LoginSubscribe_Purchase
Close
If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_Multimedia_LoginSubscribe_Purchase
Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close

Name Your Search

Save Search
Close
With a personal account, you can:
  • Track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
jn-learning_Modal_SaveSearch_NoAccess_Purchase
Close

Lookup An Activity

or

Close

My Saved Searches

You currently have no searches saved.

Close

My Saved Courses

You currently have no courses saved.

Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close